Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-22 Purchase |
2021-01-22 4:26 pm |
Prevail Therapeutics Inc. | PRVL | Tyto Acquisition Corp ELI LILLY & Co 10% Owner |
34,284,789 | $22.5 | $771,407,753 | 100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-22 Equity Swap |
2021-01-26 5:20 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner |
13,822,463 | $0 | 0 (Indirect) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:19 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO |
2,385,756 | $0 | 0 (Direct) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:13 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer |
13,000 | $0 | 0 (Direct) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:12 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Nader Francois Director |
23,747 | $0 | 0 (Indirect) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:07 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Nussbaum Ran Director |
1,576,881 | $0 | 0 (Indirect) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:06 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner |
13,822,463 | $0 | 0 (Indirect) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:05 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner |
13,822,463 | $0 | 0 (Indirect) |
View |
| 2020-12-30 Exercise |
2020-12-31 4:54 pm |
N/A 2028-03-05 |
Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO |
125,793 | $0 | 3,893,656 (Direct) |
View |
| 2020-12-30 Tax Withholding |
2020-12-31 4:54 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO |
89,037 | $23.02 | 3,893,656 (Direct) |
View |
| 2020-12-30 Exercise |
2020-12-31 4:54 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO |
120,537 | $10.26 | 3,893,656 (Direct) |
View |
| 2020-12-30 Exercise |
2020-12-31 4:54 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO |
5,256 | $0.18 | 3,893,656 (Direct) |
View |
Ownership |
2020-12-16 8:07 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Tyto Acquisition Corp ELI LILLY & Co 10% Owner |
0 | $0 | 0 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 08:30 am |
N/A 2030-09-09 |
Prevail Therapeutics Inc. | PRVL | Carson William H. Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:40 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:39 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | Sheng Morgan Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:38 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | Nussbaum Ran Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:37 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:37 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | Adams Timothy M Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:36 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | Nader Francois Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-03 6:43 pm |
N/A 2030-06-02 |
Prevail Therapeutics Inc. | PRVL | Schwartz Kira M. General Counsel |
100,000 | $0 | 100,000 (Direct) |
View |